Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 22476796)

Published in Acta Neurochir (Wien) on April 03, 2012

Authors

Sang-Bok Lee1, Dal-Soo Kim, Pil-Woo Huh, Do-Sung Yoo, Tae-Gyu Lee, Kyoung-Suok Cho

Author Affiliations

1: Department of Neurosurgery, Uijongbu St. Mary's Hospital, The Catholic University of Korea School of Medicine, Uijongbu, 480-130, Korea.

Articles by these authors

Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett (2005) 1.66

Ischaemic stroke after acute intracranial haemorrhage in patients with moyamoya disease: six new cases and a short literature review. Acta Neurochir (Wien) (2011) 1.56

Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem (2004) 1.53

Comparison of the effect of decompressive craniectomy on different neurosurgical diseases. Acta Neurochir (Wien) (2008) 1.44

Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol (2008) 1.20

Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells (2010) 1.11

Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats. J Comp Neurol (2009) 1.07

Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro. FEBS Lett (2010) 0.97

Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells. Childs Nerv Syst (2007) 0.95

CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas. Biochem Biophys Res Commun (2011) 0.94

Effect of single growth factor and growth factor combinations on differentiation of neural stem cells. J Korean Neurosurg Soc (2008) 0.94

Diagnostic method for differentiating external hydrocephalus from simple subdural hygroma. J Neurosurg (2006) 0.89

Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway. Biochem Biophys Res Commun (2003) 0.88

Risk factors and surgical treatment for symptomatic adjacent segment degeneration after lumbar spine fusion. J Korean Neurosurg Soc (2009) 0.88

Simple excision and periosteal reattachment for the treatment of calcified cephalhematoma. Technical note. J Neurosurg (2007) 0.87

Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir (Tokyo) (2012) 0.87

Congenital defect of the posterior arch of cervical spine : report of three cases and review of the current literature. J Korean Neurosurg Soc (2010) 0.87

Merlin neutralizes the inhibitory effect of Mdm2 on p53. J Biol Chem (2003) 0.87

Hybrid surgery of multilevel cervical degenerative disc disease : review of literature and clinical results. J Korean Neurosurg Soc (2012) 0.86

Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci (2003) 0.85

Ruptured right posterior inferior cerebellar artery aneurysm associated with hypoplasia of the right vertebral artery and both internal carotid arteries. Br J Neurosurg (2009) 0.85

Role of phospholipase D1 in neurite outgrowth of neural stem cells. Biochem Biophys Res Commun (2005) 0.84

Spinal cord injury in cervical spinal stenosis by minor trauma. World Neurosurg (2009) 0.84

Cranioplasty effect on the cerebral hemodynamics and cardiac function. Acta Neurochir Suppl (2008) 0.83

Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides. Cell Transplant (2007) 0.83

Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results. Clin Neurol Neurosurg (2006) 0.83

Combined direct anastomosis and encephaloduroarteriogaleosynangiosis using inverted superficial temporal artery-galeal flap and superficial temporal artery-galeal pedicle in adult moyamoya disease. Surg Neurol (2006) 0.81

Intracranial atherosclerotic disease; current options for surgical or medical treatment. J Korean Neurosurg Soc (2007) 0.80

Early superficial temporal artery to middle cerebral artery bypass in acute ischemic stroke. Clin Neurol Neurosurg (2012) 0.80

Pituitary abscess in a pregnant woman. J Clin Neurosci (2007) 0.80

Thoracic spinal cord epidural hematoma after extracorporeal shock wave lithotripsy. J Neurosurg Spine (2011) 0.78

Thirteen-year Experience of 44 Patients with Adult Hemorrhagic Moyamoya Disease from a Single Institution: Clinical Analysis by Management Modality. J Cerebrovasc Endovasc Neurosurg (2013) 0.78

Motor-evoked potential confirmation of functional improvement by transplanted bone marrow mesenchymal stem cell in the ischemic rat brain. J Biomed Biotechnol (2011) 0.78

Surgical treatment of craniovertebral junction instability : clinical outcomes and effectiveness in personal experience. J Korean Neurosurg Soc (2010) 0.78

Advanced lipid extraction method for the determination of the phospholipase D activity. Arch Pharm Res (2003) 0.77

Motion style acupuncture treatment (MSAT) for acute low back pain with severe disability: a multicenter, randomized, controlled trial protocol. BMC Complement Altern Med (2011) 0.76

Extreme thrombocytosis in a traumatic patient. Korean J Anesthesiol (2013) 0.75

MAP, a protein interacting with a tumor suppressor, merlin, through the run domain. Biochem Biophys Res Commun (2004) 0.75

Clinical results of intraarterial thrombolysis according to tPA administration and perfusion/diffusion mismatching. Acta Neurochir (Wien) (2015) 0.75

Novel consensus of management guidelines for severe traumatic brain injury in Asia. J Neurotrauma (2010) 0.75

Sudden cortical blindness in an adult with moyamoya disease. Surg Neurol (2006) 0.75

Amyloid beta peptide (Abeta42) activates PLC-delta1 promoter through the NF-kappaB binding site. Biochem Biophys Res Commun (2003) 0.75

In vivo effects of the fungicide ethaboxam on microtubule integrity in Phytophthora infestans. Pest Manag Sci (2005) 0.75

Identification of the elements regulating the expression of the phospholipase C delta1. Mol Cells (2002) 0.75